| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.079 | 0.08 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.08 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.08 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.09 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.09 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.09 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.09 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |